Mino Y
Third Department of Internal Medicine, Okayama University Medical School, Japan.
Nihon Jinzo Gakkai Shi. 1990 Apr;32(4):353-64.
We produced 22 different kinds of monoclonal antibody (Mab) by immunizing mice with human GBM antigens. In these Mabs, Mab-G1 to G5 recognized only GBM in the glomerulus, Mab-E1 and E2 recognized only glomerular epithelial cells, and Mab-M1 to M4 recognized mainly mesangium. The reactions of these Mabs with known GBM antigens such as type IV collagen, fibronectin and laminin were negative by immunoblotting. Using Mab-G1, Mab-E1 and Mab-M1, changes in the antigenicity of antigens recognized by Mabs were examined on kidney sections from the patients with various renal diseases by the indirect immunofluorescence test. When Mab-G1 recognizing GBM was used, there was no particular change of antigenicity in minimal change nephrotic syndrome (MCNS) and IgA nephropathy (IgA), whereas in membranous nephropathy (MN) thickened GBM was found to maintain antigenicity and the region of deposits was observed as negative punched-out region. In type I and III of membranoproliferative glomerulonephritis (MPGN), GBM was observed only outside of subendothelial deposits without showing double contour. In type II MPGN, GBM showed a double linear pattern and antigenicity of GBM in regions of dense deposits was not detected. When Mab-E1 recognizing glomerular epithelial cells was used, there was no change of antigenicity in the renal diseases. Further, in crescentic glomerulonephritis, the region of the cellular crescents was not stained. When Mab-M1 recognizing mesangium was used, extensive staining was observed in the increased mesangium in IgA, MPGN, and diabetic nephropathy. We feel that it is of significance in elucidating the pathogenesis of renal diseases to study the changes of glomerular antigenicity in diseased kidneys by using anti-human renal monoclonal antibodies.
我们用人脑胶质瘤抗原免疫小鼠,制备了22种不同的单克隆抗体(Mab)。在这些单克隆抗体中,Mab-G1至G5仅识别肾小球中的肾小球基底膜(GBM),Mab-E1和E2仅识别肾小球上皮细胞,而Mab-M1至M4主要识别系膜。通过免疫印迹法检测,这些单克隆抗体与已知的GBM抗原如IV型胶原、纤连蛋白和层粘连蛋白的反应均为阴性。使用Mab-G1、Mab-E1和Mab-M1,通过间接免疫荧光试验在各种肾脏疾病患者的肾切片上检测单克隆抗体识别的抗原的抗原性变化。当使用识别GBM的Mab-G1时,微小病变肾病(MCNS)和IgA肾病(IgA)中抗原性没有特别变化,而在膜性肾病(MN)中,增厚的GBM被发现保持抗原性,沉积物区域表现为阴性打孔区。在膜增生性肾小球肾炎(MPGN)的I型和III型中,仅在内皮下沉积物外观察到GBM,未显示双轨征。在II型MPGN中,GBM呈双线性模式,致密沉积物区域未检测到GBM的抗原性。当使用识别肾小球上皮细胞的Mab-E1时,肾脏疾病中抗原性没有变化。此外,在新月体性肾小球肾炎中,细胞新月体区域未染色。当使用识别系膜的Mab-M1时,在IgA、MPGN和糖尿病肾病中系膜增加的区域观察到广泛染色。我们认为,使用抗人肾单克隆抗体研究患病肾脏中肾小球抗原性的变化对于阐明肾脏疾病的发病机制具有重要意义。